| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
See Remarks | Sr VP, Clinical Research &Dev
1 company
Bryce Richard Paul serves as a See Remarks at PBYI. Across recent SEC filings that breaks down to 0 buys and 41 sells. Those positions are worth an estimated $1.1M at current prices.
The biggest single holding is PBYI (~$1.1M) as See Remarks. The recent filings there lean toward selling, a net 62,888 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 2, 2019 | PBYI Puma Biotechnology, Inc. | See Remarks | Sell | 94 | $9.00 | $846.00 | -0.3% | |
| Jul 22, 2019 | PBYI Puma Biotechnology, Inc. | See Remarks | Sell | 1,841 | $10.10 | $18,588.76 | -4.8% | |
| Jul 2, 2019 | PBYI Puma Biotechnology, Inc. | See Remarks | Sell | 89 | $12.78 | $1,137.42 | -0.2% | |
| Jun 3, 2019 | PBYI Puma Biotechnology, Inc. | See Remarks | Sell | 88 | $15.07 | $1,326.16 | -0.2% | |
| May 2, 2019 | PBYI Puma Biotechnology, Inc. | See Remarks | Sell | 85 | $32.38 | $2,752.31 | -0.2% | |
| Apr 2, 2019 | PBYI Puma Biotechnology, Inc. | See Remarks | Sell | 88 | $35.78 | $3,148.65 | -0.2% | |
| Mar 4, 2019 | PBYI Puma Biotechnology, Inc. | See Remarks | Sell | 88 | $38.66 | $3,402.08 | -0.2% | |
| Feb 4, 2019 | PBYI Puma Biotechnology, Inc. | See Remarks | Sell | 89 | $27.77 | $2,471.53 | -0.3% | |
| Jan 22, 2019 | PBYI Puma Biotechnology, Inc. | See Remarks | Sell | 1,959 | $24.72 | $48,426.48 | -6.3% | |
| Jan 3, 2019 | PBYI Puma Biotechnology, Inc. | See Remarks | Sell | 1,210 | $20.67 | $25,010.70 | -3.7% |